$982,669,952 in Total Settlement Funds Available. See if you qualify!Find Out More

KaloBios Pharmaceuticals, Inc. (Martin Shkreli) Settlement
(KBIO)
Settlement

Claim Deadline: June 18, 2018

Settlement Fund: $1,500,000

Settlement Class

All persons or entities that PURCHASED OR OTHERWISE ACQUIRED SHARES OF KALOBIOS PHARMACEUTICALS, INC. (“KALOBIOS”) COMMON STOCK BETWEEN NOVEMBER 19, 2015, AND DECEMBER 16, 2015, INCLUSIVE.

Important Documents

Settlement Notice

Proof Of Claim

Settlement Status

Disbursed

Class Period

November 19, 2015 - December 16, 2015

Settlement Hearing Date

August 02, 2018

Opt-Out Deadline

July 12, 2018

Settlement Website

https://www.strategicclaims.net/kalobios/

Claims Admin

Strategic Claims Services
KaloBios Pharmaceuticals, Inc. Securities Litigation
c/o Strategic Claims Services
600 North Jackson Street, Suite 205 Media, PA 19063
+1 400-4__-____
info@strategicclaims.net

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.